| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 407 |
| 1 | METHOTREXATE SODIUM | 394 |
| 2 | ADALIMUMAB | 384 |
| 3 | METHOTREXATE | 361 |
| 4 | INFLIXIMAB | 231 |
| 5 | ETANERCEPT | 195 |
| 6 | RITUXIMAB | 182 |
| 7 | ADALIMUMAB-AATY | 173 |
| 8 | ADALIMUMAB-ADAZ | 173 |
| 9 | ADALIMUMAB-FKJP | 173 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPROPION HYDROBROMIDE | 13 | 0.0225 |
| 1 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 2 | 0.0204 |
| 2 | BACILLUS CALMETTE-GUERIN | 18 | 0.0101 |
| 3 | GOLD | 57 | 0.0098 |
| 4 | DICLOFENAC SODIUM/MISOPROSTOL | 4 | 0.0090 |
| 5 | AMMONIUM CHLORIDE | 2 | 0.0080 |
| 6 | ZICONOTIDE ACETATE | 17 | 0.0070 |
| 7 | STREPTOMYCIN | 7 | 0.0061 |
| 8 | DIMENHYDRINATE | 65 | 0.0061 |
| 9 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 753 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 461 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 397 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 361 |
| 4 | Proton Pump Inhibitor [EPC] | 200 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 194 |
| 6 | Opioid Agonist [EPC] | 184 |
| 7 | Vitamin C [EPC] | 169 |
| 8 | Provitamin D2 Compound [EPC] | 160 |
| 9 | Antirheumatic Agent [EPC] | 159 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 39 | 0.0567 |
| 1 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 18 | 0.0101 |
| 3 | Provitamin D2 Compound [EPC] | 160 | 0.0054 |
| 4 | Antimycobacterial [EPC] | 88 | 0.0036 |
| 5 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 6 | Rifamycin Antimycobacterial [EPC] | 11 | 0.0031 |
| 7 | Interleukin-17A Antagonist [EPC] | 112 | 0.0030 |
| 8 | Chemokine Receptor Type 4 Interaction [EPC] | 4 | 0.0029 |
| 9 | Nucleoside Analog Antifungal [EPC] | 4 | 0.0028 |